Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusheng Guo

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
European Journal of Medical Research|July 5, 2023
Association of the pretreatment lung immune prognostic index with immune checkpoint inhibitor outcomes in patients with advanced hepatocellular carcinomaTao Sun, Yusheng Guo, Bo Sun, et al.
Scientific Reports|May 25, 2026
Preoperative lung immune prognostic index (LIPI) predicts postoperative outcomes in clear cell renal cell carcinoma: a multicenter studyZhenliang Pan, Yi Li, Jie Lou, et al.
Abdominal Radiology (New York)|April 21, 2026
Habitat-based radiomics-clinical analysis for early prediction of bladder cancer recurrence: a retrospective cohort studyYanjie Yang, Bingxin Gong, Xiangchuang Kong, et al.
Journal of Immunology Research|March 27, 2023
Network-Based Method to Investigate the Promoted Cell Apoptosis Mechanisms of Oridonin in OSCC through the RNA-TranscriptomeGuohui Wu, Yusheng Guo, Yang Liu, et al.
Frontiers in Immunology|December 8, 2025
The crossroads of inflammation and nutrition: predicting neoadjuvant immunochemotherapy efficacy in esophageal squamous cell carcinoma patientsGuisheng Zhang, Bingxin Gong, Yusheng Guo, et al.
Scientific Reports|January 10, 2024
Ablation alone is noninferior to radiotherapy plus ablation in the patients with early-stage hepatocellular carcinoma: a population-based studyYusheng Guo, Hebing Chen, Jiayu Wan, et al.
International Journal of Molecular Sciences|February 25, 2023
Gain-of-Function p53N236S Mutation Drives the Bypassing of HRas<sup>V12</sup>-Induced Cellular Senescence via PGC-1αHao Yang, Ke Zhang, Yusheng Guo, et al.
Neurosurgical Review|April 8, 2026
MRI semantic features as prognostic indicators and biological mechanism insights in glioblastoma multiformeYuxi Gui, Jie Lou, Yusheng Guo, et al.
Therapeutic Advances in Medical Oncology|May 19, 2026
Hepatic immune prognostic index as a prognostic biomarker in hepatocellular carcinoma patients treated with transarterial chemoembolizationJing Li, Yi Ren, Guilin Zhang, et al.
Cancer Treatment and Research Communications|February 5, 2026
Prognostic value of the baseline triglyceride-glucose-body mass index in small cell lung cancer undergoing chemoimmunotherapy: A multicenter retrospective studyDongyong Zhu, Yusheng Guo, Weiwei Liu, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
European Journal of Medical Research|July 5, 2023
Association of the pretreatment lung immune prognostic index with immune checkpoint inhibitor outcomes in patients with advanced hepatocellular carcinomaTao Sun, Yusheng Guo, Bo Sun, et al.
Scientific Reports|May 25, 2026
Preoperative lung immune prognostic index (LIPI) predicts postoperative outcomes in clear cell renal cell carcinoma: a multicenter studyZhenliang Pan, Yi Li, Jie Lou, et al.
Abdominal Radiology (New York)|April 21, 2026
Habitat-based radiomics-clinical analysis for early prediction of bladder cancer recurrence: a retrospective cohort studyYanjie Yang, Bingxin Gong, Xiangchuang Kong, et al.
Journal of Immunology Research|March 27, 2023
Network-Based Method to Investigate the Promoted Cell Apoptosis Mechanisms of Oridonin in OSCC through the RNA-TranscriptomeGuohui Wu, Yusheng Guo, Yang Liu, et al.
Frontiers in Immunology|December 8, 2025
The crossroads of inflammation and nutrition: predicting neoadjuvant immunochemotherapy efficacy in esophageal squamous cell carcinoma patientsGuisheng Zhang, Bingxin Gong, Yusheng Guo, et al.
Scientific Reports|January 10, 2024
Ablation alone is noninferior to radiotherapy plus ablation in the patients with early-stage hepatocellular carcinoma: a population-based studyYusheng Guo, Hebing Chen, Jiayu Wan, et al.
International Journal of Molecular Sciences|February 25, 2023
Gain-of-Function p53N236S Mutation Drives the Bypassing of HRas<sup>V12</sup>-Induced Cellular Senescence via PGC-1αHao Yang, Ke Zhang, Yusheng Guo, et al.
Neurosurgical Review|April 8, 2026
MRI semantic features as prognostic indicators and biological mechanism insights in glioblastoma multiformeYuxi Gui, Jie Lou, Yusheng Guo, et al.
Therapeutic Advances in Medical Oncology|May 19, 2026
Hepatic immune prognostic index as a prognostic biomarker in hepatocellular carcinoma patients treated with transarterial chemoembolizationJing Li, Yi Ren, Guilin Zhang, et al.
Cancer Treatment and Research Communications|February 5, 2026
Prognostic value of the baseline triglyceride-glucose-body mass index in small cell lung cancer undergoing chemoimmunotherapy: A multicenter retrospective studyDongyong Zhu, Yusheng Guo, Weiwei Liu, et al.
Pageof 8